News Sentiment

MBX sentiment intelligence

MBX Biosciences, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 62.92 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+3.1% over one week, +46.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

MBX Biosciences (NASDAQ:MBX) Rating Lowered to "Sell" at Wall Street Zen

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 3.1% Price confirming higher
Trend fit Trend active 46.2% over four weeks
Fair value 179.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 30
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
MarketBeat 7
TradingView 6
Investing.com 3
simplywall.st 3
Stock Titan 2
TIKR.com 2
Barron's 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 17
Analyst action 6
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49